# FDA Inspection 826416 - Terrebonne General Health System - April 04, 2013

Source: https://www.keypedia.com/records/fda_inspections/terrebonne-general-health-system/2a5e9543-ad0f-4eb7-9c1d-b600e2780d38
Source feed: FDA_Inspections

> FDA Inspection 826416 for Terrebonne General Health System on April 04, 2013. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 826416
- Company Name: Terrebonne General Health System
- Inspection Date: 2013-04-04
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1283764 - 2025-09-09](https://www.keypedia.com/records/fda_inspections/terrebonne-general-health-system/67398d25-536c-4845-b7de-79203dd5c4aa)
- [FDA Inspection 1283764 - 2025-09-09](https://www.keypedia.com/records/fda_inspections/terrebonne-general-health-system/0368d70b-07ec-45ce-8878-f3fd4329473d)
- [FDA Inspection 1217492 - 2023-08-24](https://www.keypedia.com/records/fda_inspections/terrebonne-general-health-system/999bad2f-f86b-4db5-9b10-71c44912dda9)
- [FDA Inspection 1102308 - 2019-08-28](https://www.keypedia.com/records/fda_inspections/terrebonne-general-health-system/9447e0e7-709f-480b-b697-d7b017c553c3)
- [FDA Inspection 1000028 - 2017-02-10](https://www.keypedia.com/records/fda_inspections/terrebonne-general-health-system/6e427052-7fa3-4bc9-849e-a42c83b475c5)

Company: https://www.keypedia.com/companies/terrebonne-general-health-system/7b7ea427-a275-42d9-914a-ef84af0f4cd3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d